Skip to main content
IXICO PLC logo

IXICO PLC — Investor Relations & Filings

Ticker · IXI ISIN · GB00BFXR4C20 LEI · 2138005M1F59O6HWSA97 IL Professional, scientific and technical activities
Open in API
Filings indexed 354 across all filing types
Latest filing 2020-07-08 Report Publication Anno…
Country GB United Kingdom
Listing IL IXI

About IXICO PLC

https://www.ixico.com/

IXICO PLC is a clinical research and data analytics company specializing in neuroscience. It provides neuroimaging and digital biomarker analytics to biopharmaceutical firms conducting clinical trials for neurological disorders. The company utilizes its proprietary, AI-driven technology platform to manage and analyze complex imaging and digital health data. This platform deploys disease-specific algorithms to generate reliable clinical data and precision insights, aiming to accelerate research and development decision-making, de-risk clinical studies, and support the advancement of new therapies for conditions such as Alzheimer's and Huntington's disease.

Recent filings

Filing Released Lang Actions
Conference attendance - On Helix Digital
Report Publication Announcement Classification · 1% confidence The document begins with 'RNS Number : 3203S' and contains information typical of a regulatory news service announcement from the London Stock Exchange. The content announces the company's digital attendance at an external conference ('On Helix Digital') and mentions that a pre-recorded presentation will be made available on the company website shortly after the event. Since the document is short (3601 chars) and primarily serves to announce an upcoming event and the subsequent availability of presentation material, rather than being the presentation itself or a comprehensive financial report, it fits best under the category for general regulatory announcements or announcements about report publication. Given the explicit RNS header and the nature of announcing external participation and future content availability, 'Regulatory Filings' (RNS) is the most appropriate general classification, although 'Report Publication Announcement' (RPA) is also plausible if the focus was solely on the presentation link. However, RNS is the explicit source identifier used in the document.
2020-07-08 English
Grant of share options
Remuneration Information Classification · 1% confidence The document is explicitly marked with "RNS Number : 0464S" and contains information about the granting of share options to senior leadership and employees under an EMI Share Option Plan. This type of announcement, detailing insider transactions (specifically option grants to executives/directors) and being distributed via the RNS system, strongly suggests a filing related to insider dealings or a general regulatory announcement. Since the core content is about granting options to directors/executives (Lammert Albers, Robin Wolz, Sylke Grootoonk), it relates to executive compensation/insider activity. However, the most specific category for personal share transactions by directors is 'Director's Dealing' (DIRS). While option grants are slightly different from open-market trades, in the context of these specific codes, DIRS is the closest fit for executive share-based remuneration changes, although 'SHA' (Share Issue/Capital Change) is also relevant due to the issuance of options. Given the focus on specific executives receiving options, DIRS is a strong candidate, but the document is fundamentally a regulatory announcement distributed via RNS. Since it details the grant of options to directors/executives, it falls under insider activity. If DIRS is interpreted strictly as open-market trades, then RNS (General Regulatory Filings) is the fallback. However, option grants to insiders are often captured under DIRS or sometimes DEF 14A (Remuneration). Given the short length and RNS header, RNS is the safest general classification, but let's re-evaluate against DIRS. DIRS is defined as 'Report of personal share transactions by company directors and executives (insider trades)'. Option grants are a form of insider transaction. Let's check the other options. It is not a DIV, CAP, or SHA in the primary sense. Given the RNS header and the nature of the announcement (granting options to management), RNS is the most appropriate general regulatory filing code when a more specific code like DIRS might be reserved for open-market trades. Since it is a standard RNS announcement, I will classify it as RNS, which is the general regulatory filing category for LSE announcements not covered elsewhere.
2020-07-06 English
Trading Update
Earnings Release Classification · 1% confidence The document is identified by the 'RNS Number' header and explicitly states it is providing information via RNS, which is the news service of the London Stock Exchange. The content is a 'Trading Update' providing preliminary financial performance expectations (£9.1m revenues, £0.9m EBITDA) for the fiscal year ended September 30, 2020, and outlook for FY21. This type of preliminary financial announcement, which is not the full comprehensive report (like a 10-K or IR), fits best under the 'Earnings Release' (ER) category, as it announces key financial highlights ahead of a formal filing. Although it is distributed via RNS, the content is specific enough to be classified as ER rather than the general fallback RNS. FY 2020
2020-06-24 English
Half yearly report to 31 March 2020
Earnings Release Classification · 1% confidence The document explicitly states it announces 'unaudited interim results for the six months ended 31 March 2020'. It contains detailed financial highlights, a CEO commentary on performance, and a Consolidated Statement of Comprehensive Income covering a six-month period. This content structure is characteristic of a comprehensive financial report for a period shorter than a year. The filing is identified by the RNS Number and the title 'Half yearly report to 31 March 2020'. This directly maps to the definition of an Interim / Quarterly Report (IR). It is not an Earnings Release (ER) because it is a comprehensive report, not just highlights, and it is not a 10-K as it covers a half-year period. H1 2020
2020-05-20 English
Notice of Results
Report Publication Announcement Classification · 1% confidence The document is a short announcement (2697 characters) identified by the RNS Number and the London Stock Exchange footer. The core content is a 'Notice of Results' stating that the company 'announces it will release its interim results for the six months ended 31 March 2020 on Wednesday 20 May 2020.' This structure—announcing the future publication date of a report (Interim Results)—fits the definition of a Report Publication Announcement (RPA). It is not the full Interim Report (IR) itself, nor is it a general regulatory filing (RNS) since a more specific category applies.
2020-05-12 English
Trading update for H1 2020
Earnings Release Classification · 1% confidence The document is identified by the RNS Number header and explicitly states it is an update ahead of the full results for the six months ended 31 March 2020. It provides key financial highlights (revenue, cash balance, order book) but explicitly states that the full results will be released later on May 20, 2020. This structure—a brief announcement of key preliminary figures before the comprehensive report—is characteristic of an Earnings Release (ER). It is not the full Interim Report (IR) itself, nor is it a general regulatory filing (RNS) as it fits the specific 'ER' definition. H1 2020
2020-04-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.